Analysis of human brain tissue derived from DBS surgery

Abstract

Background Transcriptomic and proteomic profiling of human brain tissue is hindered by the availability of fresh samples from living patients. Postmortem samples usually represent the advanced disease stage of the patient. Furthermore, the postmortem interval can affect the transcriptomic and proteomic profiles. Therefore, fresh brain tissue samples from living patients represent a valuable resource of metabolically intact tissue. Implantation of deep brain stimulation (DBS) electrodes into the human brain is a neurosurgical treatment for, e.g., movement disorders. Here, we describe an improved approach to collecting brain tissues from surgical instruments used in implantation of DBS device for transcriptomics and proteomics analyses. Methods Samples were extracted from guide tubes and recording electrodes used in routine DBS implantation procedure to treat patients with Parkinson’s disease, genetic dystonia and tremor. RNA sequencing was performed in tissues extracted from the recording microelectrodes and liquid chromatography-mass spectrometry (LC-MS) performed in tissues from guide tubes. To assess the performance of the current approach, the obtained datasets were compared with previously published datasets representing brain tissues. Results Altogether, 32,034 RNA transcripts representing the unique Ensembl gene identifiers were detected from eight samples representing both hemispheres of four patients. By using LC-MS, we identified 734 unique proteins from 31 samples collected from 14 patients. The datasets are available in the BioStudies database (accession number S-BSST667). Our results indicate that surgical instruments used in DBS installation retain brain material sufficient for protein and gene expression studies. Comparison with previously published datasets obtained with similar approach proved the robustness and reproducibility of the protocol. Conclusions The instruments used during routine DBS surgery are a useful source for obtaining fresh brain tissues from living patients. This approach overcomes the issues that arise from using postmortem tissues, such as the effect of postmortem interval on transcriptomic and proteomic landscape of the brain, and can be used for studying molecular aspects of DBS-treatable diseases.

Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver

“…RNA-sequencing data deposited in the Gene Expression Omnibus (GSE120064) was used to study MC1R expression in human liver biopsy samples from patients diagnosed with NAFLD (n=51) or NASH (n=155) and healthy obese control cases (n=10) without any biochemical or histological evidence or NAFLD ( Govaere et al, 2020 ). Raw data were processed using FIMM-RNAseq data analysis workflow (version 2.0.7) ( Kangas et al, 2022 ). Raw reads were preprocessed using Trim Galore (version 0.6.6).…”

Blood‐Based Proteomics for Adult‐Onset Focal Dystonias

“…Several studies also reported proteomic findings for cell or animal models of dystonia associated with the HPRT1 gene 28–31 . One study reported proteomics results for 3 cases with inherited dystonia from material sticking to electrodes used for mapping during deep brain stimulation surgery 32 . Each of these studies revealed some abnormalities likely to be specific to the monogenic disorder studied or the type of sample used, so they are difficult to compare to results reported from the current study.…”

Detection of brain somatic mutations in focal cortical dysplasia during epilepsy presurgical workup

“…Moreover, an SEEG-based approach has the potential to be applied to other conditions (with confirmed or suspected mosaic mutations) that are treated using deep brain stimulation through intracranial recording electrodes, most notably psychiatric (treatment-resistant depression and obsessive-compulsive disorder, Tourette’s syndrome) or neurologic diseases (Parkinson’s disease, genetic dystonia and tremor). 35 …”